feedback

Course Directors

Emma Guttman-Yassky, MD, PhD
Emma Guttman-Yassky, MD, PhD

Icahn School of Medicine
Mount Sinai Medical Center
New York, New York

Weily Soong, MD
Weily Soong, MD

Alabama Allergy & Asthma Center
Clinical Research Center of Alabama
Birmingham, Alabama

Accredited by

Medical Learning Institute, Inc.

Activity Details

Credit Types: CME / MOC
Credit Amount: 0.75
Release Date: 2018-Apr-17
Expiration Date: 2019-Apr-16
Estimated Time for Completion: 45 minutes
Registration Required: No
Cost: Free of charge


Expert commentary is based on data presented at the 2018 Annual Meeting of the American Academy of Dermatology and the 2018 American Academy of Allergy, Asthma, and Immunology and World Allergy Organization Joint Congress*
*PeerView is an independent publisher of conference news and medical education programs.

Activity Description and Educational Objectives

In this activity, experts in allergic and inflammatory diseases share clinical updates from the American Academy of Dermatology and the American Academy of Allergy, Asthma & Immunology/World Allergy Organization annual meetings.

Upon completion of this activity, participants should be better able to:
  • Discuss emerging data for the efficacy and safety of approved and investigational treatments for allergic and inflammatory diseases
  • Incorporate late-breaking data into individualized treatment plans for patients with allergic and inflammatory diseases

Target Audience

This activity has been designed to meet the educational needs of dermatologists, allergists, immunologists, pulmonologists, and other clinicians involved in the management of patients with allergic and inflammatory diseases.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 70% or higher is needed to obtain CME/MOC credit. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/MOC credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: April 17, 2018 - April 16, 2019
Time to Complete: 45 minutes

Faculty & Disclosure / Conflict of Interest Policy

Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME/MOC activity during the past 12 months.

Course Directors

Emma Guttman-Yassky, MD, PhD
The Sol and Clara Kest Professor of Dermatology
Vice Chair for Research, Department of Dermatology
Director, Center of Excellence in Eczema and Laboratory for Inflammatory Skin Diseases
Icahn School of Medicine
Mount Sinai Medical Center
New York, New York

Emma Guttman-Yassky, MD, PhD, has a financial interest/relationship or affiliation in the form of:
Consultant for AbbVie Inc.; Allergan; Almirall, S.A.; Amgen Inc.; Anacor Pharmaceuticals Inc.; AnaptysBio, Inc.; Asana BioSciences, LLC; Bristol-Myers Squibb Company; Celgene Corporation; Curadim Pharma Co., Ltd.; Dermira, Inc.; Eli Lilly and Company; Escalier Biosciences B.V.; Galderma Laboratories, L.P.; Glenmark Pharmaceuticals Limited; Kymab; Kyowa Kirin Pharmaceutical Development, Inc.; LEO Pharma Inc.; MedImmune; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Regeneron; sanofi-aventis U.S. LLC; Sienna Biopharmaceuticals; Stiefel Laboratories, Inc./GlaxoSmithKline; Theravance Biopharma; and Vitae Pharmaceuticals.
Grant/Research Support from Bristol-Myers Squibb Company; Celgene Corporation; Dermira, Inc.; Eli Lilly and Company; Glenmark Pharmaceuticals Limited; Janssen Pharmaceuticals, Inc.; LEO Pharma Inc.; MedImmune; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; and Regeneron. (Research grants to institution)
Emma Guttman-Yassky, MD, PhD, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: treatment of atopic dermatitis.

Weily Soong, MD
Partner, Alabama Allergy & Asthma Center
Medical Director, Clinical Research Center of Alabama
Birmingham, Alabama

Weily Soong, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for AstraZeneca.
Grant/Research Support from 3M; Aimmune Therapeutics; AstraZeneca; Circassia; F. Hoffmann-La Roche Ltd/Genentech, Inc.; Galderma Laboratories, L.P.; GlaxoSmithKline; LEO Pharma Inc.; Menlo Therapeutics; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Regeneron; Stallergenes Greer; and Teva Pharmaceuticals USA.
Speakers Bureau participant with AstraZeneca; Circassia; F. Hoffmann-La Roche Ltd/Genentech, Inc.; Regeneron/sanofi-aventis U.S. LLC; and Teva Pharmaceuticals USA.
Advisory Board for AbbVie Inc.; AstraZeneca; F. Hoffmann-La Roche Ltd/Genentech, Inc.; GlaxoSmithKline; Regeneron; and Teva Pharmaceuticals USA.
Weily Soong, MD, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: therapies for the treatment of asthma, nasal polypsis, and eosinophilic esophagitis.

CME Reviewers

Kaushal Patel, MD
Internal Medicine
Camp Hill, Pennsylvania

Kaushal Patel, MD, has no financial interests/relationships or affiliations in relation to this activity.

Tracy L. Greene, MSN, RN, NP-C
Consultant
Tampa, Florida

Tracy L. Greene, MSN, RN, NP-C, has no financial interests/relationships or affiliations in relation to this activity.

Medical Director

Kate Nelson, PhD
PVI, PeerView Institute for Medical Education
Kate Nelson, PhD, has no financial interests/relationships or affiliations in relation to this activity.

Disclaimer

The information provided at this CME/MOC activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

Providership, Credit & Support

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. The Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Learning Institute, Inc. designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The European Union of Medical Specialists (UEMS)-European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 Credit™ into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).

ABIM MOCSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Participation information will be shared with ABIM through the ACCME’s Program Reporting and Activity System (PARS). Individual or aggregated participant data may be shared with the funder of the activity.

Providership

This CME/MOC activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.

Support

This educational activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. For approved prescribing information, please consult the manufacturer’s product labeling.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.

About This CME/MOC Activity

PVI, PeerView Institute for Medical Education, and Medical Learning Institute, Inc. are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI and Medical Learning Institute, Inc.

Copyright © 2000-2018, PeerView

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.